ADVM - Adverum Biotechnologies, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,4552,319572
Cost of Revenue---
Gross Profit1,4552,319572
Operating Expenses
Research Development31,67025,46216,976
Selling General and Administrative24,35522,1077,998
Non Recurring60,7142,5732,573
Total Operating Expenses---
Operating Income or Loss-115,284-47,823-24,402
Income from Continuing Operations
Total Other Income/Expenses Net762370-984
Earnings Before Interest and Taxes-114,522-47,453-25,386
Interest Expense--18
Income Before Tax-114,522-47,453-25,404
Income Tax Expense-775--
Minority Interest---
Net Income From Continuing Ops-113,747-47,453-25,404
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-113,747-47,453-25,404
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-113,747-47,453-28,634